scispace - formally typeset
C

Cécile Couchoud

Researcher at University of Lyon

Publications -  237
Citations -  5137

Cécile Couchoud is an academic researcher from University of Lyon. The author has contributed to research in topics: Dialysis & Medicine. The author has an hindex of 34, co-authored 174 publications receiving 3934 citations.

Papers
More filters
Journal ArticleDOI

Prevalence, screening and treatment of chronic kidney disease in people with type 2 diabetes in France: the ENTRED surveys (2001 and 2007).

TL;DR: In this article, the authors assess the prevalence, quality of screening and treatment of chronic kidney disease (CKD), and their trends between 2001 and 2007, in French adults with type 2 diabetes (T2D).
Journal ArticleDOI

Treatment decisions for older adults with advanced chronic kidney disease

TL;DR: Obsational data suggests that dialysis does not provide a survival benefit for older adults with poor mobility and high levels of comorbidity, and many older adults may prefer to delay dialysis until there is a definitive indication or may opt for conservative management without dialysis.
Journal ArticleDOI

Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis

Enrico Vidal, +116 more
TL;DR: Pat characteristics at dialysis therapy initiation, prospective survival, and time to transplantation were very similar for infants initiated on PD or HD therapy, despite a widespread preconception that HD should be reserved for cases in which PD is not feasible.
Journal ArticleDOI

Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007–2011

TL;DR: The data demonstrate the need to reinforce strategies for optimal management of patients with diabetes to improve prevention, or delay the onset, of diabetic nephropathy, ESRD and cardiovascular comorbidities, and to reduce the rate of emergency dialysis.
Journal ArticleDOI

Benefits of kidney transplantation for a national cohort of patients aged 70 years and older starting renal replacement therapy.

TL;DR: Elderly kidney transplantation survival benefit in people aged ≥70 who were receiving renal replacement therapy (RRT) and their risk factors for posttransplant mortality were evaluated, including diabetes, cardiovascular comorbidities, and dialysis duration >2 years.